{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:12:23Z","timestamp":1789837943869,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bjid.2022.102739","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T04:46:54Z","timestamp":1672721214000},"page":"102739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study"],"prefix":"10.1016","volume":"27","author":[{"given":"Veena","family":"Sreedharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-1452","authenticated-orcid":false,"given":"K.V. Bhaskara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2022.102739_bib0001","first-page":"341","article-title":"Ten years of Kala-Azar in west Bengal, Part I. Did post-Kala-Azar dermal leishmaniasis initiate the outbreak in 24-Parganas?","volume":"70","author":"Addy","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bjid.2022.102739_bib0002","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.16-0151","article-title":"Molecular and serological evidence of Leishmania infection in stray dogs from visceral leishmaniasis\u2013endemic areas of Bangladesh","volume":"95","author":"Akter","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bjid.2022.102739_bib0003","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2022.102739_bib0004","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/13102818.2005.10817203","article-title":"Characterization of production of an extracellular proteinase inhibitor from Streptomyces chromofuscus 34\u20131 with alkaline phosphatase activity and antiviral effect","volume":"19","author":"Angelova","year":"2005","journal-title":"Biotechnol Biotechnol Equipment"},{"key":"10.1016\/j.bjid.2022.102739_bib0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7164\/antibiotics.22.283","article-title":"Leupeptins, new protease inhibitors from actinomycetes","volume":"22","author":"Aoyagi","year":"1969","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00508-008-1072-8","article-title":"Sandflies and sandfly-borne infections of humans in Central Europe in the light of climate change","volume":"120","author":"Asp\u00f6ck","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.bjid.2022.102739_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01612663","article-title":"Antibiotic activity of marine microorganisms","volume":"13","author":"Baam","year":"1966","journal-title":"Helgol\u00e4nder wissenschaftliche Meeresuntersuchungen"},{"key":"10.1016\/j.bjid.2022.102739_bib0008","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.88.6.2356","article-title":"Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase","volume":"88","author":"Baba","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bjid.2022.102739_bib0009","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4269\/ajtmh.2000.63.184","article-title":"Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective","volume":"63","author":"Bern","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bjid.2022.102739_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-3156.2009.02279.x","article-title":"The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India","volume":"14","author":"Boelaert","year":"2009","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.bjid.2022.102739_bib0011","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"Brotherton","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2022.102739_bib0012","doi-asserted-by":"crossref","first-page":"e26660","DOI":"10.1371\/journal.pone.0026660","article-title":"Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin\u2013susceptible\u2013resistant Leishmania donovani","volume":"6","author":"Chawla","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2022.102739_bib0013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj20020386","article-title":"Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein","volume":"367","author":"Corradin","year":"2002","journal-title":"Bioch J"},{"key":"10.1016\/j.bjid.2022.102739_bib0014","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bjid.2022.102739_bib0015","first-page":"357","article-title":"Leishmania\/HIV co-infections in the second decade","volume":"123","author":"Cruz","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bjid.2022.102739_bib0016","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/febs.12449","article-title":"Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species","volume":"280","author":"Das","year":"2013","journal-title":"FEBS J"},{"key":"10.1016\/j.bjid.2022.102739_bib0017","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/aid.1992.8.153","article-title":"The HIV-1 protease as a therapeutic target for AIDS","volume":"8","author":"Debouck","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"10.1016\/j.bjid.2022.102739_bib0018","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","article-title":"Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background","volume":"6","author":"Decuypere","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bjid.2022.102739_bib0019","first-page":"196","article-title":"On the possibility of the occurrence of trypanosomiasis in India","volume":"7","author":"Donovan","year":"1903","journal-title":"Br Med J"},{"key":"10.1016\/j.bjid.2022.102739_bib0020","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection","volume":"51","author":"Doyle","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2022.102739_bib0022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trstmh.2007.10.005","article-title":"Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan","volume":"102","author":"Elamin","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.bjid.2022.102739_bib0023","first-page":"1707","article-title":"Purification and some properties of talopeptin (MK-I), a novel proteinase inhibitor produced by Streptomyces mozunensis MK-23","volume":"46","author":"Fukuhara","year":"1982","journal-title":"Agric Biol Chem"},{"key":"10.1016\/j.bjid.2022.102739_bib0024","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0025727300042691","article-title":"The identification of Kala-Azar and the discovery of Leishmania donovani","volume":"27","author":"Gibson","year":"1983","journal-title":"Med Hist"},{"key":"10.1016\/j.bjid.2022.102739_bib0025","doi-asserted-by":"crossref","first-page":"ra58","DOI":"10.1126\/scisignal.2000213","article-title":"Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases","volume":"2","author":"Gomez","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.bjid.2022.102739_bib0026","first-page":"46","article-title":"Neue Binnen-Mollusken aus Nordost-Brasilien","volume":"70","author":"Haas","year":"1938","journal-title":"Arch Molluskenk."},{"key":"10.1016\/j.bjid.2022.102739_bib0027","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S0031182016002031","article-title":"Evaluating drug resistance in visceral leishmaniasis: the challenges","volume":"145","author":"Hendrickx","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.bjid.2022.102739_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005889","article-title":"Towards elimination of visceral leishmaniasis in the Indian subcontinent\u2014translating research to practice to public health","volume":"11","author":"Hirve","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bjid.2022.102739_bib0029","first-page":"1725","article-title":"Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes","volume":"32","author":"Hozumi","year":"1972","journal-title":"Cancer Res"},{"key":"10.1016\/j.bjid.2022.102739_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10482-004-6544-x","article-title":"Enzyme inhibitors and other bioactive compounds from marine actinomycetes","volume":"87","author":"Imada","year":"2005","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.bjid.2022.102739_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0090972","article-title":"Protease Inhibitors from Marine Actinobacteria as a Potential Source for antimalarial compound","volume":"9","author":"Karthik","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2022.102739_bib0033","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0006-291X(75)80100-8","article-title":"Inhibitory effects of phosphoramidon on neutral metalloendopeptidases and its application on affinity chromatography","volume":"65","author":"Komiyama","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bjid.2022.102739_bib0034","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1248\/cpb.17.1896","article-title":"Isolation and characterization of leupeptins produced by Actinomycetes","volume":"17","author":"Kondo","year":"1969","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.bjid.2022.102739_bib0035","first-page":"202","article-title":"Efficacy of alpha glucosidase inhibitor from marine actinobacterium in the control of postprandial hyperglycaemia in streptozotocin (STZ) induced diabetic male Albino Wister Rats","volume":"17","author":"Kumar","year":"2018","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.bjid.2022.102739_bib0036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0971-5916.164260","article-title":"Insecticide susceptibility of Phlebotomus argentipes & assessment of vector control in two districts of West Bengal, India","volume":"142","author":"Kumar","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.bjid.2022.102739_bib0037","unstructured":"Laveran. Bulletin of the New York Academy of the Medicine. 1903;50:238-40"},{"key":"10.1016\/j.bjid.2022.102739_bib0038","series-title":"Proceedings of 15th International Conference on Antiviral Research","first-page":"A75","article-title":"Antiviral action of proteolysis inhibitor from Streptomyces species","author":"Lozitsky","year":"2002"},{"key":"10.1016\/j.bjid.2022.102739_bib0039","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tmaid.2014.09.007","article-title":"Leishmaniasis in travelers: a literature review","volume":"12","author":"Mansueto","year":"2014","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.bjid.2022.102739_bib0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.mib.2004.06.010","article-title":"Cysteine peptidases as virulence factors of Leishmania","volume":"7","author":"Mottram","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bjid.2022.102739_bib0041","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)61340-X","article-title":"Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990\u20132013: quantifying the epidemiological transition","volume":"386","author":"Murray","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bjid.2022.102739_bib0042","first-page":"526","article-title":"Microorganisms, kak geologitsheskie dieiatieu. Comm. Invsalvian Mineral lakes, St. Petersburg","volume":"21","author":"Nadson","year":"1903","journal-title":"Nat Biotechonol"},{"key":"10.1016\/j.bjid.2022.102739_bib0043","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/jo01304a025","article-title":"Structure of elasnin, a novel elastase inhibitor containing an. alpha.-pyrone ring","volume":"45","author":"Nakagawa","year":"1980","journal-title":"J Organic Chem"},{"key":"10.1016\/j.bjid.2022.102739_bib0044","first-page":"1","article-title":"Of the three cases of leishman childhood splenic infection in the lese body observed in Tunisia\u2019","volume":"3","author":"Nicolle","year":"1908","journal-title":"Les Archeives de l'Institut Pasteure Tunis"},{"key":"10.1016\/j.bjid.2022.102739_bib0045","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7164\/antibiotics.36.761","article-title":"Retrostatin, a new specific enzyme inhibitor against avian myeloblastosis virus reverse transcriptase","volume":"36","author":"Nishio","year":"1983","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0046","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7164\/antibiotics.28.757","article-title":"Revistin found by screening for inhibitors of reverse transcriptase of an oncogenic virus","volume":"28","author":"Numata","year":"1975","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0047","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1139\/m84-119","article-title":"Some properties of a highly thermostable \u03b1-amylase from a Thermoactinomyces sp","volume":"30","author":"Obi","year":"1984","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.bjid.2022.102739_bib0048","first-page":"799","article-title":"Purification and structure of a novel cysteine proteinase inhibitor, strepin P-1","volume":"49","author":"Ogura","year":"1985","journal-title":"Agric Biol Chem"},{"key":"10.1016\/j.bjid.2022.102739_bib0049","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.7164\/antibiotics.31.1116","article-title":"Isolation and characterization of elasnin, a new human granulocyte elastase inhibitor produced by a strain of Streptomyces","volume":"31","author":"Ohno","year":"1978","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.7164\/antibiotics.38.1008","article-title":"Adechlorin, a new adenosine deaminase inhibitor containing chlorine production, isolation and properties","volume":"38","author":"Omura","year":"1985","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0052","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1365-3156.2008.02110.x","article-title":"Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence?","volume":"13","author":"Ostyn","year":"2008","journal-title":"Trop Med Inter Health"},{"key":"10.1016\/j.bjid.2022.102739_bib0053","first-page":"1","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Prakash Singh","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.bjid.2022.102739_bib0054","doi-asserted-by":"crossref","first-page":"e00611","DOI":"10.1128\/mBio.00611-13","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain","volume":"4","author":"Rai","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.bjid.2022.102739_bib0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.2.2239.1401","article-title":"Further notes on Leishman's bodies","volume":"2","author":"Ross","year":"1903","journal-title":"Br Med J"},{"key":"10.1016\/j.bjid.2022.102739_bib0056","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/bmj.2.2237.1261","article-title":"Note on the bodies recently described by Leishman and Donovan","volume":"2","author":"Ross","year":"1903","journal-title":"Br Med J"},{"key":"10.1016\/j.bjid.2022.102739_bib0057","first-page":"632","article-title":"Candidate gene study of susceptibility to cutaneous leishmaniasis in Sri Lanka","volume":"15","author":"Samaranayake","year":"2010","journal-title":"Trop Med Inter Health"},{"key":"10.1016\/j.bjid.2022.102739_bib0058","doi-asserted-by":"crossref","first-page":"e4918","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"Santos","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2022.102739_bib0059","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1590\/S0074-02762007000500001","article-title":"The leishmaniases-survival and expansion in a changing world: a mini-review","volume":"102","author":"Shaw","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bjid.2022.102739_bib0062","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-3156.2006.01647.x","article-title":"Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India","volume":"11","author":"Singh","year":"2006","journal-title":"Trop Med Inter Health"},{"key":"10.1016\/j.bjid.2022.102739_bib0063","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3201\/eid1303.060242","article-title":"Leishmania donovani and cutaneous leishmaniasis, Sri Lanka","volume":"13","author":"Siriwardana","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bjid.2022.102739_bib0064","doi-asserted-by":"crossref","first-page":"e1405","DOI":"10.1371\/journal.pntd.0001405","article-title":"Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control","volume":"5","author":"Stauch","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bjid.2022.102739_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7164\/antibiotics.25.263","article-title":"Antipain, a new protease inhibitor isolated from agtinomycetes","volume":"25","author":"Suda","year":"1972","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0066","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bjid.2022.102739_bib0067","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.323.7310.419","article-title":"Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialCommentary: cost and resistance remain issues","volume":"323","author":"Sundar","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bjid.2022.102739_bib0068","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S003118201600216X","article-title":"Leishmaniasis and various immunotherapeutic approaches","volume":"145","author":"Taslimi","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.bjid.2022.102739_bib0069","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00425046","article-title":"Protease inhibitors from Streptomyces violascens","volume":"83","author":"Torstensson","year":"1972","journal-title":"Archiv f\u00fcr Mikrobiologie"},{"key":"10.1016\/j.bjid.2022.102739_bib0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1017\/S0031182017000130","article-title":"Topical tamoxifen in the therapy of cutaneous leishmaniasis","volume":"145","author":"Trinconi","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.bjid.2022.102739_bib0071","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.7164\/antibiotics.38.1344","article-title":"2\u2032-Chloropentostatin: discovery, fermentation and biological activity","volume":"38","author":"Tunac","year":"1985","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0072","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.bjid.2022.102739_bib0073","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7164\/antibiotics.23.259","article-title":"Pepstatin, a new pepsin inhibitor produced by actinomycetes","volume":"23","author":"Umezawa","year":"1970","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bjid.2022.102739_bib0074","series-title":"Mechanisms of toxicity and metabolism","first-page":"17","article-title":"Enzyme inhibitors of microbial origin","author":"Umezawa","year":"1976"},{"key":"10.1016\/j.bjid.2022.102739_bib0075","unstructured":"WHO. (2015), South-East Asia poised to defeat visceral leishmaniasis (Kala-Azar), Accessed: 2016 MAR 31."},{"key":"10.1016\/j.bjid.2022.102739_bib0076","article-title":"Leishmaniasis: epidemiological report: report of a WHO Scientific Group","year":"2016","journal-title":"Fact Sheet"},{"key":"10.1016\/j.bjid.2022.102739_bib0077","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2958.2006.05274.x","article-title":"Cysteine peptidases CPA and CPB are vital for autophagy and differentiation in Leishmania mexicana","volume":"61","author":"Williams","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bjid.2022.102739_bib0078","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jhet.5570110438","article-title":"A novel adenosine and ARA-A Deaminase inhibitor,(R)-3 (2-Deoxy-Beta-D-Erythropentofuranosyl)-3, 6, 7, 8-Tetrahydroimidazo (4, 5-D)(1, 3) Diazepin-8-OL","volume":"11","author":"Woo","year":"1974","journal-title":"J Heterocyclic Chem"},{"key":"10.1016\/j.bjid.2022.102739_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(03)00211-1","article-title":"The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function","volume":"132","author":"Yao","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bjid.2022.102739_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004244","article-title":"Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain","volume":"10","author":"Zhang","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867022004329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867022004329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T20:04:52Z","timestamp":1716235492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867022004329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1413867022004329"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102739","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease inhibitors as a potential agent against visceral Leishmaniasis: A review to inspire future study","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102739"}}